Literature DB >> 26544810

Features Associated With Metastases Among Well-Differentiated Neuroendocrine (Carcinoid) Tumors of the Appendix: The Significance of Small Vessel Invasion in Addition to Size.

David A Kleiman1, Brendan Finnerty, Toni Beninato, Rasa Zarnegar, Govind Nandakumar, Thomas J Fahey, Sang W Lee.   

Abstract

BACKGROUND: The risk of metastatic disease among carcinoid tumors of the appendix increases with tumor size. However, it is unclear if any features other than size are also associated with an increased risk of metastatic disease.
OBJECTIVE: The aim of this study was to review the characteristics of appendiceal carcinoid tumors and determine if other histologic features besides size should guide surgical decision making.
DESIGN: This study involved a retrospective case series. SETTINGS: This study was conducted at a single tertiary acute care hospital. PATIENTS: Patients diagnosed with an appendiceal carcinoid tumor between 2000 and 2014 were identified. Goblet cell carcinoids, adenocarcinomas with neuroendocrine features, and tumors from other primary locations were excluded.
INTERVENTIONS: Simple appendectomy or segmental/total colectomy with lymphadenectomy was performed. MAIN OUTCOME MEASURES: The primary outcomes measured were metastases, recurrence, and overall survival.
RESULTS: Seventy-nine patients were included. The overall incidence of metastatic disease was 10%. Patients with metastatic disease were more likely to be male (75% vs 28%, p = 0.008), have small-vessel invasion (43% vs 5%, p = 0.001), and have larger tumors (median 2.0 cm vs 0.5 cm, p < 0.001). Among tumors <2 cm, the incidence of metastases among tumors with small-vessel invasion was 60% compared with 0% among those without small-vessel invasion (p < 0.001). Among tumors ≥2 cm, the incidence of metastases was 50% irrespective of small-vessel invasion. If small-vessel invasion was used as a second indication for performing a right hemicolectomy along with size ≥2 cm, both the sensitivity and negative predictive value would have been 100% compared with 63% and 96% if size was used alone. Patients with metastatic disease had a higher incidence of recurrence (13% vs 0%, p = 0.003), but overall survival was 100% in both groups. LIMITATIONS: Small sample size, retrospective design, and limited long-term follow-up were the limitations of this study.
CONCLUSIONS: Carcinoid tumors of the appendix <2 cm with small-vessel invasion have similar metastatic potential as tumors ≥2 cm. Therefore, a recommendation for a right hemicolectomy should be considered for tumors <2 cm with small-vessel invasion. Additional prospective multicenter studies are warranted.

Entities:  

Mesh:

Year:  2015        PMID: 26544810     DOI: 10.1097/DCR.0000000000000492

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Practice Patterns and Guideline Non-Adherence in Surgical Management of Appendiceal Carcinoid Tumors.

Authors:  Danielle R Heller; Raymond A Jean; Jiajun Luo; Vadim Kurbatov; Gabriella Grisotti; Daniel Jacobs; Alexander S Chiu; Yawei Zhang; Sajid A Khan
Journal:  J Am Coll Surg       Date:  2019-03-19       Impact factor: 6.113

Review 2.  Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy.

Authors:  José Luis Muñoz de Nova; Jorge Hernando; Miguel Sampedro Núñez; Greissy Tibisay Vázquez Benítez; Eva María Triviño Ibáñez; María Isabel Del Olmo García; Jorge Barriuso; Jaume Capdevila; Elena Martín-Pérez
Journal:  World J Gastroenterol       Date:  2022-04-07       Impact factor: 5.374

Review 3.  Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.

Authors:  Peter E Goretzki; Martina T Mogl; Aycan Akca; Johann Pratschke
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

4.  The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN.

Authors:  Krystallenia I Alexandraki; Gregory Kaltsas; Simona Grozinsky-Glasberg; Kira Oleinikov; Beata Kos-Kudła; Angelika Kogut; Rajaventhan Srirajaskanthan; Michail Pizanias; Kalliopi-Anna Poulia; Clara Ferreira; Martin O Weickert; Kosmas Daskalakis
Journal:  Endocrine       Date:  2020-07-24       Impact factor: 3.633

5.  The risk of lymph node metastases and their impact on survival in patients with appendiceal neuroendocrine neoplasms: a systematic review and meta-analysis of adult and paediatric patients.

Authors:  Kosmas Daskalakis; Krystallenia Alexandraki; Evanthia Kassi; Marina Tsoli; Anna Angelousi; Athanasia Ragkousi; Gregory Kaltsas
Journal:  Endocrine       Date:  2019-09-06       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.